Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy

Laura A Jansen1, Robert F Hevner, William H Roden

  • 1Department of Neurology, University of Washington, Seattle, WA; Seattle Children's Research Institute, Seattle, WA.

Annals of Neurology
|October 15, 2013
PubMed

Insights

Pyridoxine-dependent epilepsy (PDE), caused by antiquitin (ALDH7A1) dysfunction, leads to structural brain abnormalities like focal cortical dysplasia. Antiquitin normally functions in glial cells, and its deficiency causes persistent neuronal migration defects contributing to neurodevelopmental impairments.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Pyridoxine-dependent epilepsy (PDE) is linked to ALDH7A1 mutations, causing structural brain abnormalities.
  • The precise mechanism by which antiquitin (ALDH7A1) dysfunction leads to cerebral dysgenesis remains unclear.

Observation:

  • Analysis of PDE brain tissue revealed focal cortical dysplasia, heterotopic neurons, astrogliosis, and hippocampal sclerosis.
  • Elevated lysine metabolites were detected in postmortem PDE cortex.
  • Antiquitin is normally expressed in glial cells (radial glia, astrocytes) and ependyma, but not neurons, in human and murine brains.

Findings:

  • In PDE cortex, antiquitin immunofluorescence was significantly reduced and showed perinuclear accumulation in astrocytes.
  • Antiquitin dysfunction is associated with abnormal radial neuronal organization and migration defects.
  • Structural brain malformations in PDE persist despite pyridoxine treatment.

Implications:

  • Antiquitin plays a crucial role in glial cell function and neuronal development.
  • PDE-associated structural brain defects likely contribute to neurodevelopmental impairments.
  • Understanding antiquitin's role may reveal new therapeutic targets for PDE.
Abstract

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K